Skip to content

Enterobacteria capsules in treatment of patients with insomnia clinical research on effectiveness and safety

Enterobacteria capsules in treatment of patients with insomnia clinical research on effectiveness and safety

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059129
Enrollment
Unknown
Registered
2022-04-25
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Experimental group:Oral enterobacteriaceae capsules
Control group:Oral placebo

Sponsors

Army Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. No gender limit, adults aged 18-70 years; 2. Definite diagnosis of insomnia with a course of more than 3 months (the diagnostic criteria refer to the diagnostic criteria for insomnia in the International Classification of Sleep Disorders, Third Edition (ICSD3), and Pittsburgh Sleep Quality Index score -PSQI > 15); 3. Stable vital signs, clear mind, no communication and cognitive impairment, able to cooperate with the questionnaire survey; 4. Agree to participate in the study and sign the informed consent; 5. Be able to receive return visit, follow-up examination and sample collection on time.

Exclusion criteria

Exclusion criteria: 1. Patients who took probiotics or prebiotics within 3 months before enrollment; 2. Patients who used antibiotics within 3 months before enrollment; 3. Patients with a history of heavy smoking (>=10 cigarettes/day) or dependence on alcohol, coffee and strong tea; 4. Dependent on tube feeding; 5. Have a history of severe allergies; 6. Patients with serious cardiovascular and cerebrovascular diseases, liver and kidney disorders, gastrointestinal diseases and other organic diseases; 7. Patients unable to cooperate with the study; 8. Pregnant or lactating patients; 9. Suffering from depression, anxiety, schizophrenia or other serious mental illness; 10. Suffering from secondary insomnia caused by physical or mental disorders; 11. Other patients deemed unsuitable for inclusion by the investigator.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
Gut Microbiota;Neurotransmitters;Cytokine;Sex Hormone;

Countries

China

Contacts

Public ContactWei Yanling

Army Medical Center

lingzi016@126.com+86 15310354666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026